Graham K Farrington et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 28(11), 4764-4778 (2014-07-30)
The blood-brain barrier (BBB) prevents the access of therapeutic antibodies to central nervous system (CNS) targets. The engineering of bispecific antibodies in which a therapeutic "arm" is combined with a BBB-transcytosing arm can significantly enhance their brain delivery. The BBB-permeable